
Chiropodists and podiatrists are medical practitioners, certified or uncertified, those perform the diagnosis, assessment, and treatment of ankles, feet, and rest of the lower legs. They are certified to tend people with arthritis, nail surgery, diabetes, sports injuries, corns, verrucas, etc. Technically chiropodists are not different from podiatrists, the difference in name is as a result of difference in the regional nomenclature of medical practices of Europe and American states. In the U.S they are generally known as podiatrists, whereas in Europe they are known as chiropodists. Their practice segment comprises people of all ages but with the growing complications including diabetes, etc, and wearing joints, the geriatric population forms a majority of the patient segment.
The global Chiropody & Podiatry market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Chiropody & Podiatry have their largest market in the developed nations of North America and Europe, together comprising nearly 2/3rd of the world’s total demand. This was followed by Asia-pacific and rest of the world. Growth is expected in the Asia-Pacific with increased diabetic populations and awareness. Traditional methods of medicine men currently form an equally large practitioner base in many rural parts of South Asia and Africa. Therefore, Asian markets are expected to grow larger than the North American market by the turn of the decade as the average population is comparatively higher.
This report aims to provide a comprehensive presentation of the global market for Chiropody & Podiatry, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chiropody & Podiatry.
Report Scope
The Chiropody & Podiatry market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chiropody & Podiatry market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chiropody & Podiatry companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aetna Felt
Integra LifeSciences
Algeo
GILL Podiatry
Henry Scheinetc
Segment by Type
Surgery Practices
Physiotherapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chiropody & Podiatry companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chiropody & Podiatry Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Surgery Practices
1.2.3 Physiotherapy
1.3 Market by Application
1.3.1 Global Chiropody & Podiatry Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chiropody & Podiatry Market Perspective (2019-2030)
2.2 Chiropody & Podiatry Growth Trends by Region
2.2.1 Global Chiropody & Podiatry Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chiropody & Podiatry Historic Market Size by Region (2019-2024)
2.2.3 Chiropody & Podiatry Forecasted Market Size by Region (2025-2030)
2.3 Chiropody & Podiatry Market Dynamics
2.3.1 Chiropody & Podiatry Industry Trends
2.3.2 Chiropody & Podiatry Market Drivers
2.3.3 Chiropody & Podiatry Market Challenges
2.3.4 Chiropody & Podiatry Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chiropody & Podiatry Players by Revenue
3.1.1 Global Top Chiropody & Podiatry Players by Revenue (2019-2024)
3.1.2 Global Chiropody & Podiatry Revenue Market Share by Players (2019-2024)
3.2 Global Chiropody & Podiatry Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chiropody & Podiatry Revenue
3.4 Global Chiropody & Podiatry Market Concentration Ratio
3.4.1 Global Chiropody & Podiatry Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chiropody & Podiatry Revenue in 2023
3.5 Chiropody & Podiatry Key Players Head office and Area Served
3.6 Key Players Chiropody & Podiatry Product Solution and Service
3.7 Date of Enter into Chiropody & Podiatry Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chiropody & Podiatry Breakdown Data by Type
4.1 Global Chiropody & Podiatry Historic Market Size by Type (2019-2024)
4.2 Global Chiropody & Podiatry Forecasted Market Size by Type (2025-2030)
5 Chiropody & Podiatry Breakdown Data by Application
5.1 Global Chiropody & Podiatry Historic Market Size by Application (2019-2024)
5.2 Global Chiropody & Podiatry Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chiropody & Podiatry Market Size (2019-2030)
6.2 North America Chiropody & Podiatry Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chiropody & Podiatry Market Size by Country (2019-2024)
6.4 North America Chiropody & Podiatry Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chiropody & Podiatry Market Size (2019-2030)
7.2 Europe Chiropody & Podiatry Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chiropody & Podiatry Market Size by Country (2019-2024)
7.4 Europe Chiropody & Podiatry Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chiropody & Podiatry Market Size (2019-2030)
8.2 Asia-Pacific Chiropody & Podiatry Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chiropody & Podiatry Market Size by Region (2019-2024)
8.4 Asia-Pacific Chiropody & Podiatry Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chiropody & Podiatry Market Size (2019-2030)
9.2 Latin America Chiropody & Podiatry Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chiropody & Podiatry Market Size by Country (2019-2024)
9.4 Latin America Chiropody & Podiatry Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chiropody & Podiatry Market Size (2019-2030)
10.2 Middle East & Africa Chiropody & Podiatry Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chiropody & Podiatry Market Size by Country (2019-2024)
10.4 Middle East & Africa Chiropody & Podiatry Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aetna Felt
11.1.1 Aetna Felt Company Detail
11.1.2 Aetna Felt Business Overview
11.1.3 Aetna Felt Chiropody & Podiatry Introduction
11.1.4 Aetna Felt Revenue in Chiropody & Podiatry Business (2019-2024)
11.1.5 Aetna Felt Recent Development
11.2 Integra LifeSciences
11.2.1 Integra LifeSciences Company Detail
11.2.2 Integra LifeSciences Business Overview
11.2.3 Integra LifeSciences Chiropody & Podiatry Introduction
11.2.4 Integra LifeSciences Revenue in Chiropody & Podiatry Business (2019-2024)
11.2.5 Integra LifeSciences Recent Development
11.3 Algeo
11.3.1 Algeo Company Detail
11.3.2 Algeo Business Overview
11.3.3 Algeo Chiropody & Podiatry Introduction
11.3.4 Algeo Revenue in Chiropody & Podiatry Business (2019-2024)
11.3.5 Algeo Recent Development
11.4 GILL Podiatry
11.4.1 GILL Podiatry Company Detail
11.4.2 GILL Podiatry Business Overview
11.4.3 GILL Podiatry Chiropody & Podiatry Introduction
11.4.4 GILL Podiatry Revenue in Chiropody & Podiatry Business (2019-2024)
11.4.5 GILL Podiatry Recent Development
11.5 Henry Scheinetc
11.5.1 Henry Scheinetc Company Detail
11.5.2 Henry Scheinetc Business Overview
11.5.3 Henry Scheinetc Chiropody & Podiatry Introduction
11.5.4 Henry Scheinetc Revenue in Chiropody & Podiatry Business (2019-2024)
11.5.5 Henry Scheinetc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Aetna Felt
Integra LifeSciences
Algeo
GILL Podiatry
Henry Scheinetc
Ìý
Ìý
*If Applicable.
